Running head: Hyperuricemia predicts higher mortality of HFpEF

نویسندگان

  • Takeshi Shimizu
  • Akiomi Yoshihisa
  • Yuki Kanno
  • Mai Takiguchi
  • Shunsuke Miura
  • Yuichi Nakamura
  • Hiroyuki Yamauchi
  • Takashi Owada
  • Satoshi Abe
  • Takamasa Sato
  • Satoshi Suzuki
  • Masayoshi Oikawa
  • Koichi Sugimoto
  • Hiroyuki Kunii
  • Kazuhiko Nakazato
  • Hitoshi Suzuki
  • Shu-ichi Saitoh
  • Yasuchika Takeishi
چکیده

Relationship of hyperuricemia with mortality in heart failure patients 1 with preserved ejection fraction 2 3 Takeshi Shimizu, Akiomi Yoshihisa*, Yuki Kanno, Mai Takiguchi, Akihiko 4 Sato, Shunsuke Miura, Yuichi Nakamura, Hiroyuki Yamauchi, Takashi Owada, 5 Satoshi Abe1, Takamasa Sato1, Satoshi Suzuki1,2, Masayoshi Oikawa1, Takayoshi 6 Yamaki, Koichi Sugimoto, Hiroyuki Kunii, Kazuhiko Nakazato, Hitoshi Suzuki, 7 Shu-ichi Saitoh1, and Yasuchika Takeishi1,2 8 9 Department of Cardiology and Hematology, Fukushima Medical University, 10 Fukushima, Japan; and Department of Advanced Cardiac Therapeutics, Fukushima 11 Medical University, Fukushima, Japan 12 13 Running head: Hyperuricemia predicts higher mortality of HFpEF 14 15 *Corresponding author. 16 Tel: +81 24 547 1190, Fax: +81 24 548 1821, Email: [email protected] 17 Akiomi Yoshihisa, MD, PhD. 18 Department of Cardiology and Hematology, Fukushima Medical University 19 1 Hikarigaoka, Fukushima 960-1295, Japan 20 Total word count of manuscript: 2762 words 21 Total number of tables and figures: 5 tables and 2 figures 22

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.

Serum uric acid is a predictor of cardiovascular mortality in heart failure with reduced ejection fraction. However, the impact of uric acid on heart failure with preserved ejection fraction (HFpEF) remains unclear. Here, we investigated the association between hyperuricemia and mortality in HFpEF patients. Consecutive 424 patients, who were admitted to our hospital for decompensated heart fail...

متن کامل

Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction

AIMS Heart failure with preserved ejection fraction (HFpEF) has several pathophysiological aspects, including stiffness and/or congestion of multiple organs. Poor prognosis is expected in heart failure patients with liver stiffness, which has recently been assessed by non-alcoholic fatty liver disease fibrosis score (NFS; based on aspartate aminotransferase to alanine aminotransferase ratio, pl...

متن کامل

Sex‐ and Race‐Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction

BACKGROUND Sex and race have emerged as important contributors to the phenotypic heterogeneity of heart failure with preserved ejection fraction (HFpEF). However, there remains a need to identify important sex- and race-related differences in characteristics and outcomes using a nationally representative cohort. METHODS AND RESULTS Data were obtained from the Agency for Healthcare Research an...

متن کامل

Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.

BACKGROUND Ultrafiltration (UF) is a widely used technology for inpatient management of acute decompensated heart failure in patients with volume overload. However, the safety and efficacy of UF in patients with heart failure and preserved left ventricular ejection fraction (heart failure with preserved ejection fraction [HFPEF]) need further clarification. We hypothesized that UF could be used...

متن کامل

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction

BACKGROUND Biomarkers may help us to unravel differences in the underlying pathophysiology between heart failure (HF) patients with a reduced ejection fraction (HFrEF) and a preserved ejection fraction (HFpEF). Therefore, we compared biomarker profiles to characterize pathophysiological differences between patients with HFrEF and HFpEF. METHODS AND RESULTS We retrospectively analyzed 33 bioma...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015